Description

CJC-1295 (With DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog modified with Drug Affinity Complex (DAC) technology to extend its half-life and duration of activity. This allows for sustained stimulation of growth hormone release in research models, making it ideal for studies focused on prolonged hormone signaling.

In laboratory settings, CJC-1295 (With DAC) is often explored for its potential to:

• Promote sustained growth hormone release
• Support long-acting endocrine signaling research
• Assist in recovery and tissue maintenance studies
• Contribute to metabolic and body composition research

Due to its extended activity, CJC-1295 (With DAC) is widely utilized in research models examining continuous growth hormone elevation and its downstream effects.

Key Features:

• Synthetic GHRH analog with DAC modification
• Extended half-life for sustained activity
• High-purity lyophilized powder
• Consistent and reliable for laboratory applications